Romania
· Delayed Price · Currency is RON Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 875.01 million. The enterprise value is 727.02 million.
| Market Cap | 875.01M |
| Enterprise Value | 727.02M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | Aug 18, 2025 |
Share Statistics
Biofarm has 985.37 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | 985.37M |
| Shares Outstanding | 985.37M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | -28.70% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 88.33% |
| Float | 477.14M |
Valuation Ratios
The trailing PE ratio is 11.18.
| PE Ratio | 11.18 |
| Forward PE | n/a |
| PS Ratio | 2.82 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.72 |
| P/FCF Ratio | 13.87 |
| P/OCF Ratio | 11.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.66, with an EV/FCF ratio of 11.52.
| EV / Earnings | 8.44 |
| EV / Sales | 2.34 |
| EV / EBITDA | 6.66 |
| EV / EBIT | 7.90 |
| EV / FCF | 11.52 |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.67 |
| Quick Ratio | 4.06 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 17.83% and return on invested capital (ROIC) is 11.89%.
| Return on Equity (ROE) | 17.83% |
| Return on Assets (ROA) | 10.48% |
| Return on Invested Capital (ROIC) | 11.89% |
| Return on Capital Employed (ROCE) | 17.96% |
| Revenue Per Employee | 850,213 |
| Profits Per Employee | 235,899 |
| Employee Count | 373 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.05 |
Taxes
In the past 12 months, Biofarm has paid 12.13 million in taxes.
| Income Tax | 12.13M |
| Effective Tax Rate | 12.35% |
Stock Price Statistics
The stock price has increased by +10.03% in the last 52 weeks. The beta is 0.35, so Biofarm's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +10.03% |
| 50-Day Moving Average | 0.74 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 83.23 |
| Average Volume (20 Days) | 150,746 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 310.33 million and earned 86.10 million in profits. Earnings per share was 0.08.
| Revenue | 310.33M |
| Gross Profit | 257.94M |
| Operating Income | 92.01M |
| Pretax Income | 98.23M |
| Net Income | 86.10M |
| EBITDA | 109.15M |
| EBIT | 92.01M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 149.00 million in cash and 1.01 million in debt, giving a net cash position of 147.99 million or 0.15 per share.
| Cash & Cash Equivalents | 149.00M |
| Total Debt | 1.01M |
| Net Cash | 147.99M |
| Net Cash Per Share | 0.15 |
| Equity (Book Value) | 510.59M |
| Book Value Per Share | 0.52 |
| Working Capital | 283.43M |
Cash Flow
In the last 12 months, operating cash flow was 79.06 million and capital expenditures -15.96 million, giving a free cash flow of 63.10 million.
| Operating Cash Flow | 79.06M |
| Capital Expenditures | -15.96M |
| Free Cash Flow | 63.10M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 83.12%, with operating and profit margins of 29.65% and 27.75%.
| Gross Margin | 83.12% |
| Operating Margin | 29.65% |
| Pretax Margin | 31.66% |
| Profit Margin | 27.75% |
| EBITDA Margin | 35.17% |
| EBIT Margin | 29.65% |
| FCF Margin | 20.33% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.53%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 3.53% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 33.90% |
| Buyback Yield | -0.41% |
| Shareholder Yield | 3.26% |
| Earnings Yield | 9.84% |
| FCF Yield | 7.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
| Last Split Date | Apr 30, 2008 |
| Split Type | Forward |
| Split Ratio | 1.12001 |
Scores
Biofarm has an Altman Z-Score of 8.28 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.28 |
| Piotroski F-Score | 5 |